Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Ipsen Ltd
Woman and Man Max 99 years
Ipsen Ltd
Update Il y a 4 ans
A Phase IV, Randomised, Double-blind, Dose-ranging, Study in Children and Young People to determine the Optimal Dose of Botulinum Toxin Type-A (Dysport®) in Managing the Symptoms of Hip Muscle Spasticity due to Cerebral Palsy
To compare the effectiveness of 3 doses of Dysport (5, 10 or 15 Units/Kg/painful hip) in the management of chronic hip pain due to cerebral palsy in children/young people. The primary endpoint will b...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Ipsen Ltd
Update Il y a 4 ans
To assess & compare the impact on disease control & patient & practitioner experience between the 6-monthly study drug & available 3-monthly injections. Comparison of the proportions of patients medically castrated & their PSA levels at 6 and 12 months between the 6-monthly study drug & 3-monthly injections. Review of patient satisfaction & preference for the 6-monthly study drug compared to 3-monthly injections & explore the effects of the 6-monthly study drug on the patients’ Quality of Life
Primary Study Objective The primary objective of this study is to demonstrate non-inferiority of Decapeptyl SR 22.5mg to a standard 3-monthly LHRH agonist in maintaining biochemical castration (testo...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Ipsen Ltd
Update Il y a 4 ans
A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia
To evaluate the efficacy and safety of intramuscular administration of Dysport (500 units) compared to placebo for the treatment of cervical dystonia
Country
None
organs
None
Specialty
None
unknown
More information